Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.03B P/E - EPS this Y 31.20% Ern Qtrly Grth -
Income -180.91M Forward P/E -20.90 EPS next Y 41.50% 50D Avg Chg 3.00%
Sales 540.28M PEG -0.44 EPS past 5Y - 200D Avg Chg 23.00%
Dividend N/A Price/Book N/A EPS next 5Y 12.00% 52W High Chg -10.00%
Recommedations 1.90 Quick Ratio 1.10 Shares Outstanding 140.46M 52W Low Chg 141.00%
Insider Own 26.93% ROA -12.67% Shares Float 100.76M Beta 1.40
Inst Own 67.13% ROE -1,000.48% Shares Shorted/Prior 11.93M/12.68M Price 17.14
Gross Margin 69.44% Profit Margin -33.48% Avg. Volume 1,246,875 Target Price 17.46
Oper. Margin -22.72% Earnings Date Nov 4 Volume 722,282 Change -3.65%
About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Alphatec Holdings, Inc. News
12/19/24 Alphatec Holdings (NASDAQ:ATEC shareholders incur further losses as stock declines 9.0% this week, taking one-year losses to 39%
12/09/24 ATEC to Present at the 2025 J.P. Morgan Healthcare Conference
12/02/24 Alphatec Holdings (ATEC) Slid on Higher Than Expected Cash Burn Guidance
11/28/24 3 US Growth Stocks With Insider Ownership As High As 24%
11/23/24 Alphatec Holdings, Inc. (NASDAQ:ATEC) institutional owners may be pleased with recent gains after 15% loss over the past year
11/20/24 Alphatec price target raised to $20 from $19 at Barclays
11/04/24 ATEC to Participate in Upcoming Conferences
11/02/24 Earnings Update: Alphatec Holdings, Inc. (NASDAQ:ATEC) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
10/31/24 Alphatec Holdings Inc (ATEC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
10/30/24 Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates
10/30/24 Alphatec: Q3 Earnings Snapshot
10/30/24 ATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year Guidance
10/30/24 3 US Growth Companies With High Insider Ownership Growing Revenues At 16%
10/07/24 ATEC to Report Third Quarter Financial Results on October 30, 2024
10/07/24 Zacks.com featured highlights include Argenx SE Alphatec and Olin
10/04/24 3 Best Earnings Acceleration Stocks to Buy in a Strong Q4
10/01/24 US Growth Companies With Insider Ownership Up To 29%
09/29/24 Alphatec Holdings Insiders Placed Bullish Bets Worth US$1.93m
09/18/24 ATEC to Spotlight Clinically Integrated Informatics at NASS 2024
09/02/24 US Growth Companies With High Insider Ownership For September 2024
ATEC Chatroom

User Image WitzKash Posted - 1 week ago

$ATEC Added to my watchlist.

User Image gibbydds Posted - 1 week ago

$ATEC what the heck was that end of day selloff ?

User Image SpankyMac Posted - 1 week ago

$ATEC Sitting on all my shares bought in the 5's - looking for 15 to 20....

User Image AlabamaBoss Posted - 1 week ago

$ATEC

User Image Swingsurfer88 Posted - 1 week ago

$ATEC Buying more here. Minimal risk. $15 early 2025 and $20 YE. One the best in my portfolio.

User Image gaineous Posted - 2 weeks ago

$PL $SERV Out of both after one day; sitting w/cash sometimes brings the urge or feelers maximize profits especially when the market is ripping… …but no need to add unnecessary risk when the portfolio holdings are performing well. I’ve got a few small/mods I’m sticking with like $ATEC $AUR $BKSY no need to try and grab everything increasing risk. Also/PLTR and TSLA obvious set it and forget for the time being, might as well let them do the heavy lifting. $500 right around the corner for TSLA and $100 for PLTR. Holding both (TSLL is a low price/risk on TSLA if not wanting to buy the shares outright). Trader’s Market; ride the rallies, dodge the dips. Investor’s Market; spot the winners, stay for dinner.

User Image healthcareguru Posted - 2 weeks ago

$ATEC $15 soon, $20 PT YE25…still immensely undervalued vs peer group for top-tier growth profile.

User Image Winning_calls Posted - 3 weeks ago

$ATEC 👊👊🤛

User Image Winning_calls Posted - 3 weeks ago

$ATEC pick me up @ $10.55♡◇

User Image Tobes82 Posted - 1 month ago

$ATEC loaded up big time. Minimal risk here cash flow poz, cash in the bank manager have promised no more dilution - it’s been near 20 before and will get there again no problem

User Image gaineous Posted - 1 month ago

I need $MQ to take its cue from the likes of $AUR $ATEC and $BKSY Let $APPS follow suit and we’ve got a real party. A B/O w/a nice premium and it’s a bonanza. Trader’s Market; ride the rallies, dodge the dips.

User Image healthcareguru Posted - 1 month ago

@Proforma000 $ATEC going in…

User Image Lambster2 Posted - 1 month ago

$ATEC on to 20

User Image Wonderfulnewz Posted - 1 month ago

$ATEC if they actually are cf positive in q4 and down but somehow dilute shareholders then this will get to $20 ish.

User Image erevnon Posted - 1 month ago

Barclays maintains Alphatec Holdings $ATEC at Overweight and raises the price target from $19 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image Sarahsays Posted - 1 month ago

$ATEC Alphatec price target raised to $20 from $19 at Barclays Barclays analyst Matt Miksic raised the firm's price target on Alphatec to $20 from $19 and keeps an Overweight rating on the shares. After exceeding Street expectations for sales growth, EBITDA, and easing working capital and capex, Alphatec looks on track to be cash flow positive in Q4 and free cash flow breakeven with double-digit EBITDA margins in 2025, the analyst tells investors in a research note.

User Image Unknown_Stuntman Posted - 1 month ago

$GSAT probably dip then bounce like $ATEC

User Image Itchyfingas Posted - 1 month ago

@eclass you still in $ATEC

User Image swingingtech Posted - 1 month ago

$IHI $FNA $ATEC $TNDM https://wallstreetwaves.com/analysts-forecast-10-upside-for-the-holdings-of-ihi/

User Image gaineous Posted - 1 month ago

Out of all ST trades and no plan to re-enter. At my core I’m a LT investor but can adopt to a ST trade environment when needed. We know the enthusiasm as well as conditions that come with a Trump admin., + clarity from JP, w/no data to support a big down turn sans a Black Swan event should equal a continued run for a bit Expect good names to return to prior trends or moving averages if below. Holding all longs except $LULU 6/205 $345 calls (still holding $140 2027 calls, planning on exercising) Expecting $ARHS to return to $14 Expecting a multi year, multi bagger from $AUR with 1X in 12mos or less $ATEC and $BKSY …there’s still time to get in but probably not for long. Done for the day, done for a while. Now it’s just watching and managing LT risk. Final trade will be re-entering AMD 2027 ITM LEAPs Trader’s Market; ride the rallies, dodge the dips.

User Image Lambster2 Posted - 1 month ago

$ATEC 20 in year .

User Image healthcareguru Posted - 1 month ago

$ATEC $10 incoming fast…$15 1yr PT. Bear case has evaporated. 😍🔥

User Image DarthGoat Posted - 1 month ago

$ATEC OOOOUUUUTTT +14% All calls in real time.

User Image Blackcoupe369 Posted - 1 month ago

$ATEC 📈✅

User Image gaineous Posted - 1 month ago

$ATEC “I got money in the bank, yeah! (Crank it, ay!).”- Lil Scrappy. This one was scrappy when I bought it but not anymore.

User Image Winning_calls Posted - 1 month ago

$ATEC 🏦 together

User Image Snakeydakey Posted - 1 month ago

$ATEC $DJT $NVDA $TSLA

User Image Snakeydakey Posted - 1 month ago

$ATEC $DJT no joke

User Image Snakeydakey Posted - 1 month ago

$DJT $ATEC hey check out this company! 9 consecutive days of green!!

User Image DavyDaveCharts Posted - 1 month ago

$ATEC missed this one! Up 50% since spotting potential bottoming!

Analyst Ratings
Lake Street Buy Sep 3, 24
Canaccord Genuity Buy Aug 30, 24
Needham Buy Aug 22, 24
Piper Sandler Overweight Aug 1, 24
Stifel Buy Aug 1, 24
Wells Fargo Overweight Aug 1, 24
HC Wainwright & Co. Buy Aug 1, 24
Needham Buy Aug 1, 24
Canaccord Genuity Buy Jul 25, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sponsel David EVP, SALES EVP, SALES Feb 01 Sell 16.47 36,620 603,131 639,918 02/05/24
Hunsaker Craig E EVP, PEOPLE & CULTUR.. EVP, PEOPLE & CULTURE Feb 01 Sell 16.46 39,056 642,862 1,266,069 02/05/24
Lish Scott CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Feb 01 Sell 16.47 25,210 415,209 518,457 02/05/24
Sponsel David EVP, SALES EVP, SALES Dec 21 Sell 15 2,500 37,500 557,780 12/26/23
Miles Patrick CEO CEO Sep 25 Sell 12.66 179,375 2,270,888 5,452,736 09/27/23
Miles Patrick CEO CEO Sep 18 Sell 13.42 180,000 2,415,600 5,632,111 09/20/23
Bakst Evan Director Director Aug 23 Sell 14.92 8,700 129,804 1,089,038 08/24/23
Pritzker Jennifer N. 10% Owner 10% Owner Aug 08 Buy 15.11 5,750 86,882 6,000 08/10/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Jun 27 Sell 18 107,029 1,926,522 1,120,427 06/28/23
Segal Paul Director Director Jun 12 Sell 15.15 71,329 1,080,634 100,000 06/16/23
TULLIS JAMES L L Director Director May 17 Option 3.5 261,178 914,123 658,267 05/18/23
TULLIS JAMES L L Director Director May 15 Option 3.5 261,177 914,120 575,283 05/16/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC May 15 Sell 15.29 58,238 890,459 1,227,456 05/16/23
Berkowitz Mortimer III Director Director May 12 Option 3.5 107,937 377,780 663,058 05/12/23
Miles Patrick CEO CEO May 10 Option 3.5 269,842 944,447 5,872,606 05/12/23
Segal Paul 10% Owner 10% Owner May 10 Sell 14.88 167,496 2,492,340 171,329 05/12/23
L-5 Healthcare Partners, LLC 10% Owner 10% Owner May 10 Sell 14.88 1,700,000 25,296,000 11,081,538 05/12/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Apr 24 Sell 15.85 28,311 448,729 1,285,694 04/24/23
Koning John Todd CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Apr 20 Sell 16.42 16,500 270,930 415,552 04/24/23
Miles Patrick CEO CEO Apr 04 Sell 15.86 353 5,599 5,607,764 04/06/23
TULLIS JAMES L L Director Director Mar 08 Sell 16.12 30,000 483,600 467,974 03/09/23
WOODS WARD W JR Director Director Mar 06 Option 3.5 539,683 1,888,890 2,174,604 03/08/23
Miles Patrick CEO CEO Mar 06 Sell 5348.23 180,000 962,681,400 5,748,117 03/08/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Feb 27 Sell 15.23 126,033 1,919,483 1,346,828 03/01/23
Lish Scott SVP, DEVELOPMENT SVP, DEVELOPMENT Feb 27 Option 3.5 13,493 47,226 444,015 03/01/23
Lish Scott SVP, DEVELOPMENT SVP, DEVELOPMENT Feb 27 Sell 14.76 25,372 374,491 430,522 03/01/23
Koning John Todd CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Feb 27 Sell 14.76 22,500 332,100 432,052 03/01/23
Koning John Todd CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Feb 22 Sell 14.20 13,068 185,566 470,644 02/23/23
Lish Scott SVP, DEVELOPMENT SVP, DEVELOPMENT Feb 21 Sell 14.2 22,070 313,394 453,034 02/23/23
L-5 Healthcare Partners, LLC - - Feb 17 Option 3.5 2,346,032 8,211,112 13,343,865 02/21/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Feb 17 Sell 14.04 65,716 922,653 1,472,861 02/21/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Feb 17 Option 3.5 134,921 472,224 1,570,916 02/21/23
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Feb 09 Sell 14 60,000 840,000 1,435,995 02/10/23
L-5 Healthcare Partners, LLC - - Jan 25 Option 3.5 2,000,000 7,000,000 11,530,346 01/26/23
Miles Patrick CEO CEO Jan 20 Sell 13.16 180,000 2,368,800 5,301,633 01/24/23
Miles Patrick CEO CEO Jan 17 Sell 13.23 180,000 2,381,400 5,481,633 01/19/23
TULLIS JAMES L L Director Director Dec 16 Sell 10.59 50,000 529,500 497,974 12/20/22
Sponsel David EVP, SALES EVP, SALES Dec 05 Sell 9.88 10,000 98,800 556,983 12/05/22
L-5 Healthcare Partners, LLC - - Nov 09 Option 3.5 1,000,000 3,500,000 9,242,761 11/10/22
Sponsel David EVP, SALES EVP, SALES Nov 07 Sell 9.25 10,000 92,500 566,690 11/09/22
Mowry David H Director Director Aug 29 Sell 7.85 4,370 34,304 91,973 08/29/22
Altman Elizabeth Ann Director Director Aug 17 Sell 9.06 8,009 72,562 40,431 08/17/22
Hunsaker Craig E EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC Aug 15 Sell 9.42 40,795 384,289 1,251,174 08/17/22
Pritzker Jennifer N. 10% Owner 10% Owner Aug 09 Buy 7.99 8,100 64,719 6,000 08/11/22
Snider Brian EVP, Marketing EVP, Marketing Jun 15 Option 2 50,000 100,000 676,821 06/17/22
Segal Paul 10% Owner 10% Owner Jun 14 Buy 6.91 100,000 691,000 338,825 06/16/22
Hunsaker Craig E EVP, People/Culture.. EVP, People/Culture & GC Jun 13 Sell 7.16 60,000 429,600 1,301,729 06/15/22
TULLIS JAMES L L Director Director Jun 13 Buy 6.76 7,500 50,700 187,558 06/15/22
Berkowitz Mortimer III Director Director Jun 09 Buy 7.20 16,000 115,200 555,121 06/13/22
Segal Paul 10% Owner 10% Owner Jun 09 Buy 7.14 71,329 509,289 238,825 06/13/22